<DOC>
	<DOCNO>NCT03009461</DOCNO>
	<brief_summary>According Barcelona clinic liver cancer ( BCLC ) stag treatment guideline , sorafenib recommend Hepatocellular Carcinoma ( HCC ) Portal Vein Tumor Thrombosis ( PVTT ) , HCC major PVTT ( main trunk 1st-order branch portal vein ) benefit much sorafenib previous study . There establish standard treatment HCC patient major PVTT , investigator conduct randomize , phase 2 study investigate survival benefit sorafenib plus Hepatic arterial infusion chemotherapy ( HAIC ) Oxaliplatin Fluorouracil versus sorafenib Hepatocellular Carcinoma Major Portal Vein Tumor Thrombosis .</brief_summary>
	<brief_title>Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib HCC With Major Portal Vein Tumor Thrombosis</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Patient must histologically clinically confirm hepatocellular carcinoma . HCC major PVTT ( main trunk 1storder branch portal vein ) Child A class Patient 's Eastern Cooperative Oncology Group ( ECOG ) performance status must = &lt; 2 ( Karnofsky &gt; = 60 % ) Absolute neutrophil count &gt; = 1,500/mcL Platelets &gt; = 100,000/mcL Hemoglobin &gt; = 90g/L Total bilirubin = &lt; 2 X institutional upper limit normal Aspartate aminotransferase ( AST ) ( serum glutamic oxaloacetic transaminase [ SGOT ] ) /alanine aminotransferase ( ALT ) ( serum glutamic pyruvate transaminase [ SGPT ] ) = &lt; 2.5 X institutional upper limit normality Creatinine = &lt; 1.5 X institutional upper limit normal Albumin &gt; = 30g/L Patient must able understand willing sign write informed consent document Patients prior chemotherapy Oxaliplatin Fluorouracil sorafenib . Patient receive investigational agent Patient diagnosis hepatic encephalopathy Patients diagnosis sclerosing cholangitis . Patients diagnosis Gilbert 's disease . Patients clinical ascites Patient must uncontrolled concurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , uncontrolled diabetes mellitus hypertension , psychiatric illness/social situation would limit compliance study requirement No malignancy except localize basal cell squamous cell skin cancer past 5 year Patient pregnant lactate Patient Allergic Iodine contrast medium Uncontrolled severe coagulation disorder ( INR &lt; 1.5 patient warfarin therapy )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hepatocellular carcinoma</keyword>
	<keyword>Portal vein tumor thrombosis</keyword>
	<keyword>Hepatic arterial infusion chemotherapy</keyword>
	<keyword>Sorafenib</keyword>
</DOC>